Ignite Creation Date:
2024-05-06 @ 4:06 AM
Last Modification Date:
2024-10-26 @ 11:44 AM
Study NCT ID:
NCT02456701
Status:
COMPLETED
Last Update Posted:
2017-09-05
First Post:
2015-05-20
Brief Title:
Enhancing Radioiodine Incorporation Into BRAF Mutant Thyroid Cancers With the Combination of Vemurafenib and KTN3379
Sponsor:
Organization:
Celldex Therapeutics